In This Story ME +2.49% 23andMe ( ME +2.49% ), the company that popularized at-home DNA tests, announced on Tuesday that its sales took a hit during its most recent quarter. The news comes just a day after the biotech company said it is cutting nearly half its workforce and dropping its drug discovery business. Suggested Reading Elon Musk's X is bleeding users after Trump's election win. Here's where they're going Boeing delivered its fewest planes in years. Recovering from the strike will take

Tag-uri: DNA